324 related articles for article (PubMed ID: 19446432)
21. Developmental and reproductive toxicology studies in nonhuman primates.
Chellman GJ; Bussiere JL; Makori N; Martin PL; Ooshima Y; Weinbauer GF
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):446-62. PubMed ID: 20025046
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies.
Ponce R; Abad L; Amaravadi L; Gelzleichter T; Gore E; Green J; Gupta S; Herzyk D; Hurst C; Ivens IA; Kawabata T; Maier C; Mounho B; Rup B; Shankar G; Smith H; Thomas P; Wierda D
Regul Toxicol Pharmacol; 2009 Jul; 54(2):164-82. PubMed ID: 19345250
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of juvenile toxicity.
Barrow PC; Barbellion S; Stadler J
Methods Mol Biol; 2011; 691():17-35. PubMed ID: 20972745
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of in vitro safety studies.
Suter W
Curr Opin Chem Biol; 2006 Aug; 10(4):362-6. PubMed ID: 16815733
[TBL] [Abstract][Full Text] [Related]
25. Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studies.
Benbow JW; Aubrecht J; Banker MJ; Nettleton D; Aleo MD
Toxicol Lett; 2010 Sep; 197(3):175-82. PubMed ID: 20576494
[TBL] [Abstract][Full Text] [Related]
26. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
Jacobs A
Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
[TBL] [Abstract][Full Text] [Related]
27. Applications of emerging technologies in toxicology and safety assessment.
Reynolds VL
Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
[TBL] [Abstract][Full Text] [Related]
28. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
Moser VC; Walls I; Zoetis T
Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
[TBL] [Abstract][Full Text] [Related]
29. Early clinical development: evaluation of drug-induced torsades de pointes risk.
Vik T; Pollard C; Sager P
Pharmacol Ther; 2008 Aug; 119(2):210-4. PubMed ID: 18601950
[TBL] [Abstract][Full Text] [Related]
30. Assessment of pulmonary function and serum substance levels in newborn and juvenile rats.
Lewin G; Hoymann HG; Fuhst R; Berger-Preiss E; Pohlmann G; Buschmann J
Reprod Toxicol; 2010 Nov; 30(3):422-8. PubMed ID: 20493942
[TBL] [Abstract][Full Text] [Related]
31. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the safety of drugs for animals.
Robens JF
Vet Hum Toxicol; 1979 Feb; 21(1):12-23. PubMed ID: 425289
[TBL] [Abstract][Full Text] [Related]
33. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
Reeve LM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
[TBL] [Abstract][Full Text] [Related]
34. Juvenile animal testing in drug development--is it useful?
Baldrick P
Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
[TBL] [Abstract][Full Text] [Related]
35. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry.
Lynch AM; Wilcox P
Exp Toxicol Pathol; 2011 Mar; 63(3):209-14. PubMed ID: 20060695
[TBL] [Abstract][Full Text] [Related]
36. The minipig in toxicology.
Svendsen O
Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
[TBL] [Abstract][Full Text] [Related]
37. Concordance of the toxicity of pharmaceuticals in humans and in animals.
Olson H; Betton G; Robinson D; Thomas K; Monro A; Kolaja G; Lilly P; Sanders J; Sipes G; Bracken W; Dorato M; Van Deun K; Smith P; Berger B; Heller A
Regul Toxicol Pharmacol; 2000 Aug; 32(1):56-67. PubMed ID: 11029269
[TBL] [Abstract][Full Text] [Related]
38. Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk.
Gintant GA
Pharmacol Ther; 2008 Aug; 119(2):199-209. PubMed ID: 18621077
[TBL] [Abstract][Full Text] [Related]
39. Comparative hepatic toxicity: prechronic/chronic liver toxicity in rodents.
Hardisty JF; Brix AE
Toxicol Pathol; 2005; 33(1):35-40. PubMed ID: 15805054
[TBL] [Abstract][Full Text] [Related]
40. Human radiolabeled mass balance studies: objectives, utilities and limitations.
Penner N; Klunk LJ; Prakash C
Biopharm Drug Dispos; 2009 May; 30(4):185-203. PubMed ID: 19544285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
